Illumina Inc (ILMN)

NASDAQ


	Symbol		Exchange		Currency
	ILMN		NASDAQ		USD	Real-time
	ILMN		Mexico		MXN	Delayed
	1ILMN		Milan		EUR	Real-time
	ILMN		TradeGate		EUR	Delayed
	ILMN		Frankfurt		EUR	Delayed
	I1LM34		B3		BRL	Delayed
	ILMN		Vienna		EUR	Real-time

Currency in USD

ILMN Pro Research

148.53

+1.00(+0.68%)

Closed02:29:59

After Hours

148.60+0.07(+0.05%)

05:40:20

Fair Value

Day's Range

147.54

151.75

52 wk Range

97.27

156.66

ILMN Income Statement

Featured here, the Income Statement (earnings report) for Illumina Inc, showing the company's financial performance from operating and non operating activities such as revenue, expenses and income for the last 4 periods (either quarterly or annually).

Advanced Income Statement

Period Ending:

2014

28/12

2016

03/01

2017

01/01

2017

31/12

2018

30/12

2019

29/12

2021

03/01

2022

02/01

2023

01/01

2023

31/12

Total Revenues

3,543

3,239

4,526

4,584

4,504

Total Revenues Growth

+6.3%

-8.58%

+39.73%

+1.28%

-1.75%

Cost Of Revenues

1,042

1,008

1,301

1,439

1,563

Gross Profit

2,501

2,231

3,225

3,145

2,941

Gross Profit Growth

+7.11%

-10.8%

+44.55%

-2.48%

-6.49%

Gross Profit Margin %

70.59%

68.88%

71.25%

68.61%

65.3%

Other Operating Expenses, Total

1,516

1,651

2,729

2,996

3,035

	Other Operating Expenses, Total Growth
	R&D Expenses
	Selling General & Admin Expenses
	Other Operating Expenses

aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	+4.41%	+8.91%	+65.29%	+9.78%	+1.3%
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	575	609	914	1,209	1,207
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	907	1,014	1,744	1,614	1,637
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-	-	-

Operating Income

985

580

496

149

-94

Operating Income Growth

+11.55%

-41.12%

-14.48%

-69.96%

-163.09%

EBIT Margin %

27.8%

17.91%

10.96%

3.25%

-2.09%

Net Interest Expenses

23

-8

-61

-15

-19

Net Interest Expenses Growth

+276.92%

-134.78%

-662.5%

+75.41%

-26.67%

Interest Expense, Total

-52

-49

-61

-26

-77

Interest And Investment Income

75

41

-

11

58

Other Non Operating Expenses, Total

-5

11

9

-13

1

EBT, Excl. Unusual Items

1,003

583

444

121

-112

Gain (Loss) On Sale Of Assets

54

-

-

-

-

Other Unusual Items, Total

-1

7

112

-421

-101

EBT, Incl. Unusual Items

1,118

856

884

-4,336

-1,117

EBT, Incl. Unusual Items Growth

+25.06%

-23.43%

+3.27%

-590.5%

+74.24%

EBT, Incl. Unusual Items Margin

31.56%

26.43%

19.53%

-94.59%

-24.8%

Income Tax Expense

128

200

122

68

44

Net Income to Company

990

656

762

-4,404

-1,161

Minority Interest

12

-

-

-

-

Net Income

1,002

656

762

-4,404

-1,161

Net Income Growth

+21.31%

-34.53%

+16.16%

-677.95%

+73.64%

Net Income Margin %

28.28%

20.25%

16.84%

-96.07%

-25.78%

Preferred Dividend and Other Adjustments

-

-

-

-

-

Net Income to Common Excl. Extra Items

1,002

656

762

-4,404

-1,161

Basic EPS - Continuing Operations

6.82

4.46

5.08

-28.05

-7.35

Basic EPS - Continuing Operations Growth

+21.31%

-34.53%

+13.84%

-652.18%

+73.8%

Diluted EPS - Continuing Operations

6.74

4.45

5.04

-28.05

-7.35

Diluted EPS - Continuing Operations Growth

+21.22%

-33.98%

+13.26%

-656.57%

+73.8%

Basic Weighted Average Shares Outstanding

147

147

150

157

158

Diluted Weighted Average Shares Outstanding

149

148

151

157

158

Dividend Per Share

-

-

-

-

-

Dividend Per Share Growth

-

-

-

-

-

EBITDA

1,173

767

747

543

338

EBITDA Growth

+10.45%

-34.61%

-2.61%

-27.31%

-37.75%

EBITDA Margin %